XML 58 R42.htm IDEA: XBRL DOCUMENT

Stock-Based Compensation and Stock Awards (Tables)

12 Months Ended

Dec. 31, 2020

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Option activity for the year ended December 31, 2020 was as follows:

	Number of Options			Weighted Average Price		Aggregate Intrinsic Value (in millions)		Weighted Average Remaining Contractual Life (in years)
Outstanding at December 31, 2019		132,375		$	67.85
Forfeited		(74,750	)		67.40
Outstanding at December 31, 2020		57,625		$	68.43		-		0.8

Exercisable at year-end		57,625		$	68.43		-		0.8

Summary of RSA Activity

The Company’s RSA activity and related information is presented below:

	Restricted Stock			Weighted- average Grant Date Fair Value
Unvested at December 31, 2019		348,690		$	43.16
Granted		340,107			24.24
Vested		(172,501	)		42.02
Forfeited		(35,520	)		42.88
Nonvested at December 31, 2020		480,776		$	30.20

Schedule of Valuation Assumptions

Assumptions used in the Monte Carlo simulation are as follows:

	2020		2019		2018
Grant date	October 28, 2020		October 28, 2019		October 28, 2018
Performance period	October 1, 2020 to September 30, 2023		October 1, 2019 to September 30, 2022		October 1, 2018 to September 30, 2021
Volatility	50.9%		38.8%		32.6%
Risk-free interest rate	0.2%		1.7%		2.9%
Grant date price	$	23.86	$	44.53	$	43.09

Summary of PSA Activity

The Company’s Performance Unit activity and related information is presented below:

	Number of Performance Units			Weighted Average Grant Date Fair Value Per Unit
Nonvested balance at December 31, 2019		268,550		$	52.81
Granted		264,355			40.66
Vested		(168,902	)		54.64
Forfeited		(33,036	)		53.06
Nonvested balance at December 31, 2020		330,967		$	42.10

Schedule of DSA Activity

The Company's DSA activity for the year ended December 31, 2020 is presented below:

	DSA Number of Shares			Weighted Average Grant Date Fair Value Per Share
Nonvested balance at December 31, 2019		36,320		$	44.61
Granted		58,194			29.41
Vested		(32,318	)		45.16
Nonvested balance at December 31, 2020		62,196		$	30.18

Schedule of Information for Stock Option Plans

Equity Compensation Plan Information

The following table summarizes information for equity compensation plans in effect as of December 31, 2020 :

	Number of securities to be issued upon exercise of outstanding options, warrants and rights ⁽¹⁾		Weighted- average exercise price of outstanding options, warrants and rights ⁽²⁾		Number of securities remaining available for future issuance under equity compensation plan
Plan category	(a)		(b)		(c)
Equity compensation plans approved by stockholders		388,592	$	68.43		11,897
Total		388,592	$	68.43		11,897

⁽¹⁾

^{Excludes 542,972 shares of unvested RSAs and DSAs, which were granted pursuant to the 2017 Plan and the 2004 Plan. Includes 330,967 unvested Performance Units shown at 100% level of performance achievement.}

⁽²⁾

^{The weighted average exercise price does not take into account 330,967 unvested Performance Units, which do not have an exercise price.}